387 related articles for article (PubMed ID: 18175270)
1. In silico methods for early toxicity assessment.
Merlot C
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270
[TBL] [Abstract][Full Text] [Related]
2. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
3. The value of in silico chemistry in the safety assessment of chemicals in the consumer goods and pharmaceutical industries.
Modi S; Hughes M; Garrow A; White A
Drug Discov Today; 2012 Feb; 17(3-4):135-42. PubMed ID: 22063083
[TBL] [Abstract][Full Text] [Related]
4. Computational methods to predict drug safety liabilities.
Durham SK; Pearl GM
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):110-5. PubMed ID: 11727316
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in physicochemical and ADMET profiling in drug discovery.
Wang J; Skolnik S
Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
[TBL] [Abstract][Full Text] [Related]
6. Computational toxicology in drug development.
Muster W; Breidenbach A; Fischer H; Kirchner S; Müller L; Pähler A
Drug Discov Today; 2008 Apr; 13(7-8):303-10. PubMed ID: 18405842
[TBL] [Abstract][Full Text] [Related]
7. [In silico, in vitro, in omic experimental models and drug safety evaluation].
Claude N; Goldfain-Blanc F; Guillouzo A
Med Sci (Paris); 2009 Jan; 25(1):105-10. PubMed ID: 19154704
[TBL] [Abstract][Full Text] [Related]
8. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
Bugrim A; Nikolskaya T; Nikolsky Y
Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
[TBL] [Abstract][Full Text] [Related]
9. The challenge of predicting drug toxicity in silico.
Vedani A; Dobler M; Lill MA
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):195-208. PubMed ID: 16930291
[TBL] [Abstract][Full Text] [Related]
10. A structural feature-based computational approach for toxicology predictions.
Valerio LG; Yang C; Arvidson KB; Kruhlak NL
Expert Opin Drug Metab Toxicol; 2010 Apr; 6(4):505-18. PubMed ID: 20074001
[TBL] [Abstract][Full Text] [Related]
11. Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
Gwathmey JK; Tsaioun K; Hajjar RJ
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):647-60. PubMed ID: 19442031
[TBL] [Abstract][Full Text] [Related]
12. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
Whitebread S; Hamon J; Bojanic D; Urban L
Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262
[TBL] [Abstract][Full Text] [Related]
13. What have we learned from pre-clinical juvenile toxicity studies?
Bailey GP; Mariën D
Reprod Toxicol; 2009 Sep; 28(2):226-9. PubMed ID: 19446432
[TBL] [Abstract][Full Text] [Related]
14. Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage.
Pieper IA; Bertau M
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):747-60. PubMed ID: 20367108
[TBL] [Abstract][Full Text] [Related]
15. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
Buckley LA; Dorato MA
Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
[TBL] [Abstract][Full Text] [Related]
16. Safety assessment of drug residues.
Jackson BA
J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1141-4. PubMed ID: 6894293
[TBL] [Abstract][Full Text] [Related]
17. In silico predictive toxicology: the state-of-the-art and strategies to predict human health effects.
Helma C
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):27-31. PubMed ID: 15679168
[TBL] [Abstract][Full Text] [Related]
18. Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.
Vanderwall DE; Yuen N; Al-Ansari M; Bailey J; Fram D; Green DV; Pickett S; Vitulli G; Luengo JI; Almenoff JS
Drug Discov Today; 2011 Aug; 16(15-16):646-53. PubMed ID: 21601652
[TBL] [Abstract][Full Text] [Related]
19. Improving drug safety using computational biology.
Cook D
IDrugs; 2010 Feb; 13(2):85-9. PubMed ID: 20127559
[TBL] [Abstract][Full Text] [Related]
20. Early clinical development: evaluation of drug-induced torsades de pointes risk.
Vik T; Pollard C; Sager P
Pharmacol Ther; 2008 Aug; 119(2):210-4. PubMed ID: 18601950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]